Canada markets closed

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.07500.0000 (0.00%)
At close: 03:56PM EST
Full screen
Previous Close0.0750
Open0.0800
Bid0.0700 x 0
Ask0.0750 x 0
Day's Range0.0700 - 0.0800
52 Week Range0.0600 - 0.7700
Volume236,127
Avg. Volume662,904
Market Cap10.247M
Beta (5Y Monthly)-4.40
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Vaxil Announces Change of Auditor

    Not for distribution by US newswire or in United States NESS-ZIONA, Israel , Nov. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that the board of directors of the Corporation has appointed Zeifmans LLP as the Corporation’s new auditor, replacing MNP LLP. Vaxil has filed a Notice of Change of Auditor in respect of this change under its profile on SEDAR at www.sedar.com. ABOUT VAXIL Vaxil is an Israeli immunothera

  • GlobeNewswire

    Vaxil Provides Update on Acquisition of Short Wave Pharma Inc.

    Not for distribution by US newswire or in United StatesNESS-ZIONA, Israel, Nov. 11, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that further to our press release from October 14, 2021, the Company, together with Short Wave Pharma Inc (”Shortwave"), have agreed not to pursue Vaxil's acquisition of Shortwave. The decision was reached by both entities following a due diligence process, concluding that the transaction

  • CNW Group

    IIROC Trading Resumption - VXL

    Trading resumes in: